Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who discuss life science current events on MedCityNews.com.
Now here’s the best of what YOU had to say:
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Your genes need not be your fate: Nutrigenomics to the rescue. “Nutrigenomics is the science of how bioactive chemicals in foods and supplements alter the molecular expression and/or structure of an individual’s genetic makeup. It is apparent that one size does not fit all when it comes to nutrition. We have become aware of the limitations of population-wide advice such as the food guide pyramid. Second generation approaches have proliferated with pyramids tailored for children, the elderly, ethnic groups, vegetarians, etc. ”
Weighing the risks of Pradaxa vs. the risk of stroke. “Folks, of course it is better to not have a disease that increases the risk of stroke…But blood thinners are not bad medicines. They are medicines. They have risks and they have benefits. And the alternative: a patient can have the disease and its inherent risks.”
Three ways to manage distributed authentication and protect privacy. “As the nation begins its pilots of pioneer Accountable Care Organizations and shares more data for care coordination and population management, IT departments will be asked to make clinical records available to increasing numbers of loosely affiliated clinicians and staff. ”
Integrative medicine – Part 1. “Can integrative medicine add value to standard western practices? Some would say absolutely not; others point to new scientific evidence that demonstrates the value of specific modalities in specific situations.”
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
